AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03702452 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: functional rehabilitation nursing program
Description: According to the modified Barthel index score, the patients' function was divided into four parts Level,each level has different kinds of rehabilitation nursing.
Study NCT03702452 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: control group
Description: The rehabilitation were given by the rehabilitation therapist based on the patient's condition, such as, bridge movement,limb passive motion, limb active motion,turn over,sit upw,walk, and so on.
Study NCT01815866 — intervention group
Intervention type: PROCEDURE
Intervention: CF with culturable NTM
Description: CF patients who produce culturable aerosols of NTM will receive the following test: pulmonary function test, collecting a sputum culture if possible, coughing for 5 minutes into a tube connected to a canister, hypertonic saline and albuterol will be given after the 5 minutes of coughing and then they would repeat with another 5 minutes of coughing. There can be a break inbetween the coughing if needed.
Study NCT01815099 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: rTMS Treatment
Description: Either 10 or 15 rTMS sessions (2 or 3 times/week for 5 weeks, respectively)
Study NCT01292733 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Tumor Marker Analysis
Description: Performed every 6 months, these blood samples will be drawn to measure the concentration of CA125 tumor marker. Remaining samples will be stored in a specimen repository for use in future research for ovarian and breast cancer tumor markers.
Study NCT01292733 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transvaginal Ultrasound
Description: Performed annually, these pelvic ultrasounds will be used used to look for 1) enlargement of one or both ovaries or 2) suspicious or indeterminate morphometric parameters, determined by the presence of intracystic papillations, and/or mural nodularity.
Study NCT01292733 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Status Questionnaire
Description: Performed every 6 months, these questionnaires will ask about your health and medical history, environmental exposures, and family history.
Study NCT04049344 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Decitabine; Oxaliplatin
Description: Patients receive Decitabine 10 mg/day for 5 consecutive days (d1-5) plus Oxaliplatin 75mg/m2 2-week-cycle (d6, d20) within 4 weeks. One cycle is defined as 4 weeks of treatment and total of 6 cycles are designed for patients.
Study NCT04216628 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Amniotomy
Description: Artificial rupturing of membranes and IV infusion of Oxytocin
Study NCT02367157 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Kenzo Kase Method
Study NCT02367157 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Kinesio Taping
Study NCT00395720 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: MVA85A (TB vaccine)
Description: Intradermal vaccine
Study NCT00395720 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: MVA 85A
Description: Intradermal vaccine
Study NCT01072500 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical Activity
Description: The physical activity intervention consists primarily of walking at moderate intensity, lower extremity resistance exercises, balance exercises, stretching and behavioral counseling.
Study NCT01072500 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Successful Aging
Description: The successful aging intervention consists of health education seminars regarding health-related matters and upper extremity stretching exercises.
Study NCT03225833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: WVE-120101
Description: WVE-120101 is a stereopure antisense oligonucleotide (ASO)
Study NCT03225833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 0.9% Sodium Chloride
Study NCT00829010 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine GSK1024850A
Description: Intramuscular injection, administered as 3 or 4 doses
Study NCT00829010 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tritanrix-HepB/Hib
Description: Intramuscular injection, 4 doses
Study NCT00829010 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: measles
Description: Intramuscular injection, 2 doses
Study NCT00829010 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rotarix
Description: Oral, 2 doses
Study NCT00829010 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Local OPV
Description: Oral 4 doses. Given at any time during the study, routinely given concurrently with DTPw-HBV/Hib vaccine
Study NCT02509663 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Functional Endoscopic Sinus Surgery
Description: Balloon Sinuplasty uses a small, flexible, balloon catheter to open up blocked sinus passageways and facilitate drainage of the mucus that builds up in patients suffering from frontal sinusitis symptoms. When the sinus balloon is inflated, it restructures and widens the walls of the sinus passageway while maintaining the integrity of the sinus lining.
Study NCT02509663 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Functional Endoscopic Sinus Surgery using rigide instrumentation
Description: FESS (Functional Endoscopic Sinus Surgery) using rigide instrumentation is conventional therapeutic strategy.~The procedure works by cutting to remove bone and tissue to enlarge the sinus opening.
Study NCT02509663 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sinuplasty balloon
Description: Balloon Sinuplasty uses a small, flexible, balloon catheter to open up blocked sinus passageways and facilitate drainage of the mucus that builds up in patients suffering from frontal sinusitis symptoms. When the sinus balloon is inflated, it restructures and widens the walls of the sinus passageway while maintaining the integrity of the sinus lining.
Study NCT02509663 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscope
Description: FESS (Functional Endoscopic Sinus Surgery) using rigide instrumentation is conventional therapeutic strategy.~The procedure works by cutting to remove bone and tissue to enlarge the sinus opening.
Study NCT03270527 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High SFA diet (Diet 1)
Description: 'Diet 1' will contain \~18% of its total energy as SFA .
Study NCT03270527 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low SFA diet (Diet 2)
Description: 'Diet 2' will contain \~10% of its total energy as SFA. The SFA-replacement fats will be mixture of PUFA/MUFA.
Study NCT02137902 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tobacco/Physical Activity Intervention
Description: Telemedicine stage-tailored counseling intervention focused on increasing intrinsic motivation and goal setting for tobacco and physical activity, adherence with nicotine replacement therapy (NRT, patch plus gum or lozenge), and self-monitoring with a pedometer-based walking program.
Study NCT02137902 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diet plus BP/CHOL Intervention
Description: Telemedicine stage-tailored counseling intervention focused on increasing intrinsic motivation, goal setting for managing HTN and HCL, and adherence with antihypertensives and statins with supportive dietary changes. Includes a native diet cookbook and medication bag.
Study NCT00597129 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 90Y-hPAM4
Description: Single dose of 90Y-hPAM4 will be given and all patients will be followed for 12 weeks.
Study NCT02522715 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacological Study
Description: Correlative studies
Study NCT02465957 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: aNK (NK-92)
Description: A natural killer cell line recovered from a patient with large granular lymphoma
Study NCT02465957 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: aNK (NK-92) + N-803
Description: aNK - A natural killer cell line recovered from a patient with large granular lymphoma and N-803 - Recombinant human super agonist interleukin-15 (IL-15) complex
Study NCT02522715 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Given PO
Study NCT00940394 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: psychoeducation group
Description: bi-weekly, 12-session, family psychoeducation group
Study NCT00940394 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard care
Description: Routine mental health care services provided by the outpatient clinic and related agencies for families of people with schizophrenia
Study NCT01915355 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulsed Dye Laser for the treatment of nail fungus
Description: The purpose of this research is to investigate the use of the Candela V-beam Pulsed Dye Laser for the treatment of onychomycosis, a common nail fungus.
Study NCT03800758 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expressive Helping
Description: Expressive Helping (EH) is completed in 4 brief structured writing sessions during and immediately after transplant, with instructions focused on having participants write about their transplant experience using previously-tested EH instructions, adapted for this population.
Study NCT03800758 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Factual Writing
Description: Factual Writing has been used with cancer patients and in the investigators' prior EH trial. It is completed in 4 brief structured writing sessions during and immediately after transplant, with instructions focused on having participants write about their transplant experience using standard Factual Writing instructions.
Study NCT00323518 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: velafermin
Description: administered intravenously as 100mL single dose over 15 minutes on day 1
Study NCT02878135 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: fast application
Study NCT02878135 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: slow application
Study NCT02006394 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fish Oil
Description: fish oil capsules
Study NCT02006394 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Polyphenol Capsules
Description: delphinidin polyphenol capsules
Study NCT02006394 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Corn Oil Capsules
Description: Corn Oil Capsules
Study NCT02006394 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Corn starch capsules
Description: Maltodextrin capsules
Study NCT02006394 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reduced glycemic index bread products
Description: Made by Zone Labs
Study NCT02006394 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Market variety bread products
Description: placebo bread products
Study NCT00204763 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Air filled balloon catheter
Description: The new air filled balloon catheter will be tested against the solid state catheter
Study NCT00323518 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: administered intravenously as 100mL single dose over 15 minutes on day 1
Study NCT00204763 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Solid state catheter
Description: The standardly used solid state catheter will be tested against the new air filled balloon catheter
Study NCT04105933 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CS-CBT
Description: Culturally sensitive Cognitive Behavioural Therapy was delivered individually, focused on potential cultural beliefs and attitudes that might collide with core values of CBT.
Study NCT04105933 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CBT
Description: CBT was delivered at an individual level, dealing with thoughts, feelings and behaviours in the present. Thoughts are identified and then challenged, to make them more objective and rational.
Study NCT03008083 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 3 months DAPT
Description: Subjects will continue DAPT with P2Y12 inhibitors and Aspirin (ASA) up to 90 days, after which patients will continue on monotherapy with ASA only, unless contraindications for ASA emerge.
Study NCT03008083 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 12 months DAPT
Description: Subjects will continue DAPT with P2Y12 inhibitors and Aspirin (ASA) up to 360 days, after which patients will continue on monotherapy with ASA only, unless contraindications for ASA emerge.
Study NCT02567955 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Immunogenicity two doses of Gardasil-9
Description: Subjects will receive two standard doses of Gardasil-9 (0.5 ml)
Study NCT02567955 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Immunogenicity Cervarix and Gardasil-9
Description: Subjects will receive a standard dose of Cervarix (0.5 ml) and a standard dose of Gardasil-9 (0.5 ml)
Study NCT04352114 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3461767 - SC
Description: Administered SC.
Study NCT04352114 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3461767 - IV
Description: Administered IV.
Study NCT04352114 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo - SC
Description: Administered SC.
Study NCT01675687 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Follow Up Support
Description: inputs will be based on elements derived from cognitive behavioural therapy, acceptance and commitment therapy, mindfulness and awareness training
Study NCT02029950 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Given IV
Study NCT02029950 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin Hydrochloride
Description: Given IV
Study NCT02029950 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV
Study NCT02029950 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin Hydrochloride
Description: Given IV
Study NCT02029950 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT02029950 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacological Study
Description: Correlative studies
Study NCT02029950 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: Given PO
Study NCT00807807 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Folic Acid
Description: 100 mcg, 400 mcg, 1000 mcg, or 2000 mcg of folic acid once a day for 6 weeks
Study NCT00807807 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Folic Acid
Description: Placebo folic acid once a day for 6 weeks
Study NCT03432546 — intervention group
Intervention type: OTHER
Intervention: Non-interventional
Description: Non-interventional
Study NCT01618552 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SEE IT training
Description: Standardized patient instructors provide a scripted intervention to train primary care physicians in the use of self-efficacy enhancing interviewing techniques (SEE IT) during office visits with patients who have coexisting depression and diabetes
Study NCT01618552 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Knowledge enhancement
Description: Brief video clip designed to increase primary care physician awareness of new medication treatments for diabetes
Study NCT00114465 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VSL#3
Description: VSL#3 1 sachet twice a day
Study NCT00114465 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 1 sachel twice a day
Study NCT00514033 — intervention group
Intervention type: BIOLOGICAL
Intervention: Poliomyelitis vaccine (inactivated) -PoliorixTM
Description: Deep intramuscular injections for the primary vaccination and booster vaccination.
Study NCT00987077 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Selective Retina Therapy (SRT)
Description: SRT (pulsed double-Q-switched Nd-YLF laser, wavelength 527 nm, t=1.7 µs, energy 100-370 μJ).
Study NCT03559465 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: skin biopsy
Description: A skin biopsy will be performed in 10 patients in the form of 2 punches of 5 mm in the injured area in aseptic condition with a Rodnan score.~In this study, 10 skin biopsies are needed, and will be performed on the first 10 patients accepting this biopsy.
Study NCT03559465 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Blood punction
Description: 1 blood punction during the normal pathway of care of the patient. This punction will be used to perform the extraction of B lymphocyte
Study NCT03559465 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood punction
Description: 1 blood punction during the normal pathway of care of the patient. This punction will be used to perform the extraction of B lymphocyte
Study NCT00993291 — intervention group
Intervention type: PROCEDURE
Group type: NO_INTERVENTION
Intervention: Frequency change to 60 Hz
Description: 60 Hz stimulation for one hour, done twice over the 5 hour study period in a randomized blinded fashion.
Study NCT00993291 — intervention group
Intervention type: PROCEDURE
Group type: NO_INTERVENTION
Intervention: Frequency change to 130 Hz
Description: 130 Hz Stimulation for one hour, done twice over the 5 hour study period in a randomized blinded fashion.
Study NCT01117428 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sym004
Description: In part A, patients in all dose cohorts will continue weekly treatment with the assigned dose of Sym004 until disease progression.~In Part B, patients will continue weekly treatment with the tolerated dose of Sym004 until disease progression.~In Part C, patients will receive weekly doses of Sym004 at the dose level below 12 mg/kg i.e. 9 mg/kg until disease progression.~In Part D and E, patients will receive doses of Sym004 administered every 2 weeks at dose level 12 mg/kg and 18 mg/kg, respectively until disease progression.~In Part F, patients will receive a single loading dose of 9 mg/kg followed by weekly doses of 6 mg/kg.
Study NCT03018028 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: Oral administration once daily
Study NCT03018028 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral administration once daily
Study NCT01314833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel Cyclophosphamide
Description: Docetaxel 75 mg/m² D1 Cyclophosphamide 600 mg/m² D1~1 cycle = 21 days~TC\*6
Study NCT01314833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide Fluorouracil Epirubicin Docetaxel
Description: 1st -3rd Cycle: Fluorouracil 500 mg/m² D1 Epirubicin 100 mg/m² D1 Cyclophosphamide 500 mg/m² D1~1 cycle = 21 days~4th-6th Cycle: Docetaxel 100mg/m² D1~1 cycle = 21 days CEF\*3-T\*3
Study NCT01314833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epirubicin Cyclophosphamide Paclitaxel
Description: 1st-4th Cycle: Epirubicin 90 mg/m² D1 Cyclophosphamide 600 mg/m² D1~1 cycle = 21 days~5th-8th Cycle: Paclitaxel 80mg/m² D1, 8, 15~1 cycle = 21 days EC\*4-P\*4
Study NCT01463319 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: air insufflation
Description: air insufflation during insertion phase colonoscopy
Study NCT01463319 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: warm water irrigation
Description: warm water irrigation during insertion phase colonoscopy
Study NCT03540966 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: CapulinTM
Description: a kind of camouflage agent
Study NCT03540966 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chinese version of the vitiligo life quality index, VLQI-C
Description: a questionaire designed for patients with vitiligo
Study NCT03540966 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Chinese version of the vitiligo life quality index, VLQI-C
Description: a questionaire designed for patients with vitiligo
Study NCT03018028 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Liraglutide
Description: Subcutaneous (s.c., under the skin) injection once daily
Study NCT02391155 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: single lumen needle in oocyte retrieval
Description: single lumen needle use during oocyte retrieval
Study NCT02391155 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: double lumen needle in oocyte retrieval
Description: after aspiration of follicles, 3 times flushing will be performed in double lumen needle.
Study NCT02232542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duloxetine - low dose
Study NCT02232542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duloxetine - high dose
Study NCT02232542 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo